Healthcare Attorney to Speak on Proton Therapy Access at National Conference

Brian Stimson to discuss strategies for informing policymakers and improving patient access to proton therapy.

Mar. 19, 2026 at 12:00am

On March 19, 2026, AGG Healthcare practice co-chair Brian Stimson will speak at the 2026 National Proton Conference in Nashville, Tennessee, during a session focused on strengthening patient access to proton therapy. As reimbursement pressures, coverage policies, and regulatory scrutiny continue to influence the availability of proton therapy, Stimson will examine practical approaches organizations can use to educate policymakers and advocate for appropriate patient access.

Why it matters

Proton therapy is an advanced cancer treatment that can be more effective and have fewer side effects than traditional radiation therapy, but access to this treatment option remains limited due to various policy and regulatory barriers. Stimson's session aims to provide strategies for healthcare organizations to influence decision-makers and improve patient access to this important therapy.

The details

During the session, Stimson and fellow panelists will discuss how litigation, legislative engagement, regulatory advocacy, and coordinated messaging can be used to influence policymakers at both the state and federal levels. The goal is to equip attendees with practical tools to make the case for proton therapy and ensure patients have access to this specialized cancer treatment.

  • The 2026 National Proton Conference will take place on March 19, 2026 in Nashville, Tennessee.

The players

Brian Stimson

Co-chair of the Healthcare practice at AGG, a law firm.

Got photos? Submit your photos here. ›

What’s next

To register and learn more about patient access to proton therapy, please click here.

The takeaway

This conference session aims to equip healthcare organizations with strategies to influence policymakers and improve patient access to proton therapy, an advanced cancer treatment option that remains limited in availability due to various policy and regulatory barriers.